OncoDNA is a theranostic and genomic company specialising in precision oncology.
About
The company is headquartered in Belgium and comprises two entities, IntegraGen and BioSequence. The Group works with a global network of distributors and laboratories to deliver the promises of precision medicine for cancer patients.
OncoDNA provides a unique offering of services to oncologists, research institutes and biopharmaceutical companies across the globe. Its portfolio includes comprehensive biomarker and genomic testing on solid tumour tissues and liquid biopsies, as well as advanced NGS data interpretation services. OncoDNA technology is used not only in development of new personalized therapies, but also in the selection of treatments tailored to a patient’s cancer profile.
OncoDNA provides a unique offering of services to oncologists, research institutes and biopharmaceutical companies across the globe. Its portfolio includes comprehensive biomarker and genomic testing on solid tumour tissues and liquid biopsies, as well as advanced NGS data interpretation services. OncoDNA technology is used not only in development of new personalized therapies, but also in the selection of treatments tailored to a patient’s cancer profile.